Prostate Cancer
News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.
News | Prostate Cancer | April 04, 2017
April 4, 2017 — Profound Medical Corp. announced that the first TULSA-PRO patient paid procedure has been successfully...
News | Biopsy Systems | March 30, 2017
March 30, 2017 — Analogic Corp. announced that it will introduce its bkFusion solution for improving biopsy targeting...
News | Focused Ultrasound Therapy | March 29, 2017
March 29, 2017 — EDAP TMS SA announced the publication of a peer-reviewed article that analyzed Ablatherm Robotic HIFU...
News | Radiation Therapy | March 27, 2017
March 27, 2017 — Radiation therapists and physicians know that education can reduce anxiety before radiation treatment...
News | Biopsy Systems | March 23, 2017
March 23, 2017 — Urology specialists at the Barbara Ann Karmanos Cancer Institute (Detroit) have begun using the UroNav...
News | Prostate Cancer | March 22, 2017
March 22, 2017 — Profound Medical Corp. announced that it has successfully completed the first sale of a TULSA-PRO...
News | Biopsy Systems | March 16, 2017
March 16, 2017 — Exact Imaging has received Health Canada approval and the corresponding medical device license (#98667...
CTVPOST (red) = CTVPRE (yellow) union CTVPET (pink). Also shown (upper right corner) are the PRE (square) vs POST (triangle) dose volume histograms for PTV1, PTV2, rectum, bladder, and penile bulb, showing minimal impact on target coverage or organs at risk dose with the modified targets. Image courtesy of Ashesh B. Jani, M.D., and David Schuster, M.D., Emory University.
News | Radiopharmaceuticals and Tracers | March 16, 2017
March 16, 2017 — The featured clinical investigation article of the March 2017 issue of the Journal of Nuclear Medicine...
News | Prostate Cancer | March 09, 2017
March 9, 2017 — Michigan Medicine and the University of Michigan have launched the nation’s first prostate cancer risk...
This is a single-fraction high-dose-rate prostate implant imaging and dosimetry. Image courtesy of Daniel Krauss/American Society for Radiation Oncology (ASTRO)
News | Brachytherapy Systems | March 06, 2017
March 6, 2017 — Results from a new prospective clinical trial indicate high-dose-rate (HDR) brachytherapy administered...
News | Radiation Therapy | February 17, 2017
February 17, 2017 — Accuray Inc. recently announced data from a prospective, Phase II, 17-center study which showed...
Technology | Magnetic Resonance Imaging (MRI) | February 13, 2017
February 13, 2017 — aycan recently introduced ayDCE software powered by aycan workstation. The new software helps...
News | Radiopharmaceuticals and Tracers | February 07, 2017
February 7, 2017 — Blue Earth Diagnostics and Siemens’ PETNET Solutions announced that an increasing number of...
News | Prostate Cancer | February 03, 2017
February 3, 2017 — Adding hormonal therapy to radiation treatment can significantly improve the average long-term...
Ga-68-BBN PET/CT of a 64-year-old man newly diagnosed with prostate cancer by biopsy. Multiple bone metastasis lesions (arrows) were detected. Image courtesy of Jingjing Zhang, Peking Union Medical College, Beijing, China.
News | Prostate Cancer | February 02, 2017
February 2, 2017 — In the featured article from the February 2017 issue of the Journal of Nuclear Medicine, researchers...
News | Prostate Cancer | January 18, 2017
January 18, 2017 — An article promoting standardized imaging efforts to improve diagnosis and treatment of prostate...
News | Patient Positioning Radiation Therapy | January 16, 2017
January 16, 2017 — Augmenix Inc. announced that the International Journal of Radiation Oncology Biology and Physics (...
News | Radiopharmaceuticals and Tracers | January 06, 2017
January 6, 2017 — New research demonstrates that a novel imaging agent can quickly and accurately detect metastasis of...
News | Focused Ultrasound Therapy | December 22, 2016
Insightec Ltd. announced that the Exablate Prostate system received CE Mark for treating locally-confined prostate...
News | Prostate Cancer | December 22, 2016
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and...